Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis

Condition:   Generalized Myasthenia Gravis
Interventions:   Biological: Ravulizumab;   Drug: Placebo
Sponsor:   Alexion Pharmaceuticals
Recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days